AU6028298A - Enhancement of hematopoietic cells - Google Patents

Enhancement of hematopoietic cells

Info

Publication number
AU6028298A
AU6028298A AU60282/98A AU6028298A AU6028298A AU 6028298 A AU6028298 A AU 6028298A AU 60282/98 A AU60282/98 A AU 60282/98A AU 6028298 A AU6028298 A AU 6028298A AU 6028298 A AU6028298 A AU 6028298A
Authority
AU
Australia
Prior art keywords
prolactin
interleukin
composition
cells
hematopoietic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU60282/98A
Other languages
English (en)
Inventor
Dan L. Longo
William J Murphy
Susan M. Richards
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genzyme Corp
National Institutes of Health NIH
Original Assignee
Genzyme Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genzyme Corp filed Critical Genzyme Corp
Publication of AU6028298A publication Critical patent/AU6028298A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2257—Prolactin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU60282/98A 1997-01-21 1998-01-20 Enhancement of hematopoietic cells Abandoned AU6028298A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3587597P 1997-01-21 1997-01-21
US60035875 1997-01-21
PCT/US1998/000887 WO1998031385A1 (en) 1997-01-21 1998-01-20 Enhancement of hematopoietic cells

Publications (1)

Publication Number Publication Date
AU6028298A true AU6028298A (en) 1998-08-07

Family

ID=21885308

Family Applications (1)

Application Number Title Priority Date Filing Date
AU60282/98A Abandoned AU6028298A (en) 1997-01-21 1998-01-20 Enhancement of hematopoietic cells

Country Status (5)

Country Link
EP (1) EP1049485A1 (ja)
JP (1) JP2001516341A (ja)
AU (1) AU6028298A (ja)
CA (1) CA2277482A1 (ja)
WO (1) WO1998031385A1 (ja)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6183756B1 (en) 1997-05-01 2001-02-06 Dynagen, Inc. Methods for prevention and/or treatment of thrombocytopenia

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL82885A (en) * 1987-06-15 1991-07-18 Migal Galilee Technology Cente Method and composition containing a peptide hormone for stimulating growth in poultry
US4837202A (en) * 1987-09-14 1989-06-06 Pitman-Moore, Inc. Method for stimulating the immune system
US5696128A (en) * 1994-07-07 1997-12-09 The Board Of Supervisors Of Louisiana University And Agricultural And Mechanical College Method of regulating immune function
CA2183260A1 (en) * 1994-02-14 1995-08-17 Susan Richards Prolactin as a vaccine adjuvant
US5888980A (en) * 1994-06-30 1999-03-30 Bio-Logic Research And Development Corporation Compositions for enhancing immune function

Also Published As

Publication number Publication date
WO1998031385A1 (en) 1998-07-23
EP1049485A1 (en) 2000-11-08
CA2277482A1 (en) 1998-07-23
JP2001516341A (ja) 2001-09-25

Similar Documents

Publication Publication Date Title
CA2087525C (en) Adoptive immunotherapy with interleukin-7
US5632983A (en) Method for treating secondary immunodeficiency
Geissler et al. Recombinant human interleukin-3 expands the pool of circulating hematopoietic progenitor cells in primates--synergism with recombinant human granulocyte/macrophage colony-stimulating factor
EP0831888B1 (en) Methods for increasing hematopoietic cells
ES2321189T3 (es) Estimulacion de la hematopoyesis por medio de celulas inmunitarias activadas ex vivo.
WO1995006475A1 (en) Increase in hematopoietic progenitor cells in peripheral blood by transforming growth factor beta
Sun et al. Recombinant human prolactin improves antitumor effects of murine natural killer cells in vitro and in vivo
AU6028298A (en) Enhancement of hematopoietic cells
WO1998031385A9 (en) Enhancement of hematopoietic cells
WO1994018991A1 (en) EXPANSION OF STEM CELLS IN LONG TERM BONE MARROW CULTURES BY NEUTRALIZATION OF TGF-$g(b)
Sun et al. Human prolactin improves engraftment and reconstitution of human peripheral blood lymphocytes in SCID mice
Sun et al. Immunologic and hematopoietic effects of recombinant human prolactin after syngeneic bone marrow transplantation in mice
EP0473696B1 (en) Avian Interleukin-2 for enhancing growth in birds
Li et al. Cytokines transduced bone marrow stromal cell lines promote immunohematopoietic reconstitution in mice after allogeneic bone marrow transplantation
EP1871872B1 (en) Method for activating cd8 t cells
US20050004037A1 (en) Osteogenic growth oligopeptides as stimulants of hematopoiesis
Frasca et al. Activation of gp130 signaling in vivo by the IL‐6 super‐agonist K‐7/D‐6 accelerates repopulation of lymphoid organs after irradiation
RU2272810C2 (ru) Средство для активации стволовых клеток
Togni Hematopoietic regulation by catecholamines
AU2001282436A1 (en) Osteogenic growth oligopeptides as stimulants of hematopoiesis
Roncarolo et al. Effects of Cytokine Administration on Human Hematopoiesis in SCID-hu Mice
Khanna et al. Hematopoietic growth factors in transplantation: Biology and applications
WO1993005801A1 (en) Use of il-5 to treat solid tumors
MXPA97009244A (en) Methods to increase hematopoyeti cells

Legal Events

Date Code Title Description
MK1 Application lapsed section 142(2)(a) - no request for examination in relevant period